JUNE 2026 ISSUE OF APPLIED POLICY INSIGHT
The June 2026 issue of Insight explores the international implications of Most Favored Nation drug pricing policies and their effects on pharmaceutical market access strategies. Sampat Nidadavolu reports on the June HCPCS Public Meeting and Annie Tuttle recaps a Northern…
MAY 2026 ISSUE OF APPLIED POLICY INSIGHT
In the May 2026 issue of Insight, Emma Hammer reviews changes to CMS drug pricing model timelines, Simay Okyay McNutt examines CMS’s request for information on prior authorization for laboratory services and DMEPOS, and Linda O’Neill discusses healthcare preparedness as…
APRIL 2026 ISSUE OF APPLIED POLICY INSIGHT
The April 2026 issue of Insight features Emma Hammer’s assessment of the implementation status of Executive Order 14273 on drug pricing, one year after its issuance, and Sabrina Luther’s examination of stakeholder concerns about the DMEPOS moratorium and CRUSH Request…
MARCH 2026 ISSUE OF APPLIED POLICY INSIGHT
In the March 2026 issue of Insight, William Rogers, M.D. examines the roots of Medicare coverage for kidney transplantation. Meghan Basler examines the newly finalized Ambulatory Specialty Model, and Emma Hammer and Caitlyn Bernard Shreve contrast the ACCESS and MAHA…
FEBRUARY 2026 ISSUE OF APPLIED POLICY INSIGHT
In the February 2026 issue of Insight, Emma Hammer observes that recent drug pricing deals and CMS initiatives reflect an active policy agenda, though many details have yet to be clarified. Annie Tuttle examines the ACCESS model, and we share our…
JANUARY 2026 ISSUE OF APPLIED POLICY INSIGHT
The January 2026 issue of Insight features analysis of the 340B Drug Pricing Program from Stephanie Lomas, Emma Hammer, and Caitlyn Bernard Shreve; examines the MAHA Elevate, GUARD, GLOBE, and BALANCE models; and highlights a new white paper on using federal tax…
DECEMBER 2025 ISSUE OF APPLIED POLICY INSIGHT
In the December 2025 edition of Insight, Dr. Bill Rogers examines how skin substitutes came to represent 15% of drug spending under traditional Medicare, Simay Okyay provides an update on the RID CBP, and Caitlyn Bernard considers how the Trump Administration is…
NOVEMBER 2025 ISSUE OF APPLIED POLICY INSIGHT
In the November 2025 edition of Insight, Sabrina Luther discusses how medical food may—or may—not fit in the Trump Administration’s upcoming definition of ultra-processed foods, Caitlyn Bernard provides a summary of the Physician Fee Schedule final rule for CY 2026, and Annie…
OCTOBER 2025 ISSUE OF APPLIED POLICY INSIGHT
In the October 2025 edition of Insight, Meghan Basler considers could be one of the most substantial downward adjustments in recent years under the current home health payment framework, Simay Okyay McNutt looks at the history of Medicare’s consideration of obesity,…
SEPTEMBER 2025 ISSUE OF APPLIED POLICY INSIGHT
In the September 2025 edition of Insight, Brittany La Couture examines the paradox in QPP, Meghan Basler analyzes what the WISeR model may signal for prior authorization in fee-for-service Medicare, and Simay Okyay considers the pending decision on the RID Competitive…
AUGUST 2025 ISSUE OF APPLIED POLICY INSIGHT
In the August 2025 edition of Insight, Emma Hammer provides a detailed look at where federal agencies stand in the implementation of President Trump’s Executive Order 14273: Lowering Drug Prices by Once Again Putting Americans First. We also consider the dawn of…
